Healthcare provider profile · identity verified

Lindsay Braun, M.D.

Family Practice · GRESHAM, OR · NPI 1821354366

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	533	109
Omeprazole	Omeprazole	297	57
Levothyroxine Sodium	Levothyroxine Sodium	264	39
Lisinopril	Lisinopril	229	60
Amlodipine Besylate	Amlodipine Besylate	189	49
Metformin Hcl	Metformin Hcl	181	46
Losartan Potassium	Losartan Potassium	129	31
Albuterol Sulfate Hfa	Albuterol Sulfate	127	36
Gabapentin	Gabapentin	121	32
Trazodone Hcl	Trazodone Hcl	116	27
Carvedilol	Carvedilol	98	18
Simvastatin	Simvastatin	93	18
Hydrochlorothiazide	Hydrochlorothiazide	82	22
Ibuprofen	Ibuprofen	75	26
Pantoprazole Sodium	Pantoprazole Sodium	72	15
Quetiapine Fumarate	Quetiapine Fumarate	70	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	69	15
Tamsulosin Hcl	Tamsulosin Hcl	66	12
Lamotrigine	Lamotrigine	64	suppressed
Bupropion Xl	Bupropion Hcl	63	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	63	19
Famotidine	Famotidine	61	14
Metformin Hcl Er	Metformin Hcl	61	21
Propranolol Hcl	Propranolol Hcl	61	suppressed
Metoprolol Succinate	Metoprolol Succinate	60	13
Jardiance	Empagliflozin	57	11
Sertraline Hcl	Sertraline Hcl	56	17
Xarelto	Rivaroxaban	52	suppressed
Duloxetine Hcl	Duloxetine Hcl	50	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	50	suppressed
Divalproex Sodium	Divalproex Sodium	49	suppressed
Buspirone Hcl	Buspirone Hcl	48	suppressed
Eliquis	Apixaban	47	suppressed
Lorazepam	Lorazepam	47	suppressed
Pregabalin	Pregabalin	47	11
Mounjaro	Tirzepatide	46	suppressed
Clotrimazole	Clotrimazole	45	suppressed
Fluticasone Propionate	Fluticasone Propionate	44	20
Glipizide	Glipizide	43	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	42	suppressed
Alendronate Sodium	Alendronate Sodium	41	14
Furosemide	Furosemide	41	15
Levetiracetam	Levetiracetam	39	suppressed
Clopidogrel	Clopidogrel Bisulfate	38	suppressed
Oxycodone Hcl	Oxycodone Hcl	38	14
Risperidone	Risperidone	38	suppressed
Glipizide Er	Glipizide	37	suppressed
Montelukast Sodium	Montelukast Sodium	37	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	35	suppressed
Baclofen	Baclofen	35	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	35	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	35	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	35	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	33	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	suppressed
Glimepiride	Glimepiride	30	suppressed
Finasteride	Finasteride	29	suppressed
Januvia	Sitagliptin Phosphate	28	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	28	suppressed
Loperamide	Loperamide Hcl	27	11
Ondansetron Hcl	Ondansetron Hcl	27	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	26	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	26	14
Torsemide	Torsemide	26	suppressed
Oxcarbazepine	Oxcarbazepine	25	suppressed
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Potassium Chloride	Potassium Chloride	24	suppressed
Ventolin Hfa	Albuterol Sulfate	24	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	23	suppressed
Trulicity	Dulaglutide	23	suppressed
Citalopram Hbr	Citalopram Hydrobromide	22	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	22	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	22	suppressed
Fluconazole	Fluconazole	21	suppressed
Lovastatin	Lovastatin	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Sure Comfort Pen Needle	Pen Needle, Diabetic	19	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	17	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Incruse Ellipta	Umeclidinium Bromide	16	suppressed
Meloxicam	Meloxicam	16	suppressed
Nystatin	Nystatin	16	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	16	suppressed
Allopurinol	Allopurinol	15	suppressed
Amantadine	Amantadine Hcl	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Lurasidone Hcl	Lurasidone Hcl	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Atenolol	Atenolol	14	suppressed
Benztropine Mesylate	Benztropine Mesylate	14	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Divalproex Sodium Er	Divalproex Sodium	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Gemfibrozil	Gemfibrozil	14	suppressed
Methadone Hcl	Methadone Hcl	14	suppressed
Solifenacin Succinate	Solifenacin Succinate	14	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	13	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	13	suppressed
Imipramine Hcl	Imipramine Hcl	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Levocarnitine	Levocarnitine (With Sugar)	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Perphenazine	Perphenazine	12	suppressed
Potassium Citrate Er	Potassium Citrate	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Atrovent Hfa	Ipratropium Bromide	11	suppressed
Invega Sustenna	Paliperidone Palmitate	11	suppressed
Levocarnitine	Levocarnitine	11	suppressed
Prednisone	Prednisone	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error